420 Shares in Aflac Incorporated (NYSE:AFL) Bought by Sachetta LLC

Sachetta LLC bought a new position in shares of Aflac Incorporated (NYSE:AFL) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 420 shares of the financial services provider’s stock, valued at approximately $35,000.

Other large investors have also added to or reduced their stakes in the company. Flputnam Investment Management Co. raised its position in Aflac by 0.5% during the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock worth $2,065,000 after acquiring an additional 122 shares in the last quarter. MV Capital Management Inc. raised its position in Aflac by 3.7% during the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock worth $290,000 after acquiring an additional 136 shares in the last quarter. Simon Quick Advisors LLC raised its position in Aflac by 4.9% during the fourth quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 139 shares in the last quarter. Legacy Advisors LLC raised its position in Aflac by 2.8% during the third quarter. Legacy Advisors LLC now owns 5,213 shares of the financial services provider’s stock worth $400,000 after acquiring an additional 144 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its position in Aflac by 14.6% during the third quarter. Parkside Financial Bank & Trust now owns 1,138 shares of the financial services provider’s stock worth $87,000 after acquiring an additional 145 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Trading Up 0.1 %

Shares of Aflac stock opened at $87.67 on Thursday. The company has a market capitalization of $49.82 billion, a price-to-earnings ratio of 9.68, a PEG ratio of 2.38 and a beta of 0.91. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.34. Aflac Incorporated has a 12-month low of $64.10 and a 12-month high of $88.59. The firm’s 50-day moving average price is $84.44 and its two-hundred day moving average price is $82.60.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Monday, May 6th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.08. The firm had revenue of $5.44 billion for the quarter, compared to the consensus estimate of $4.09 billion. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The business’s revenue for the quarter was up 13.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.55 earnings per share. On average, analysts forecast that Aflac Incorporated will post 6.46 earnings per share for the current fiscal year.

Aflac Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Wednesday, May 22nd will be paid a $0.50 dividend. This is an increase from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, May 21st. Aflac’s dividend payout ratio (DPR) is presently 22.08%.

Insider Activity

In other news, Director Thomas J. Kenny sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now directly owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the sale, the senior vice president now directly owns 32,825 shares in the company, valued at approximately $2,735,635.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the sale, the director now owns 17,920 shares in the company, valued at $1,516,390.40. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,600 shares of company stock worth $1,140,724. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on AFL shares. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Piper Sandler increased their price objective on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. Truist Financial increased their price objective on shares of Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a research report on Friday, May 3rd. Wells Fargo & Company increased their price objective on shares of Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, May 10th. Finally, Raymond James increased their price objective on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $82.38.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.